- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Oral probiotics have no significant impact on HbA1c levels in children with type 1 diabetes: Study
Iran: A randomized clinical trial published in Pediatric Endocrinology Diabetes and Metabolism has shed light on the effect of oral probiotics on glycated haemoglobin levels (HbA1c) in children with type 1 diabetes mellitus (T1DM).
The study showed no significant effect of consumption of oral probiotics on HbA1c levels in children with type 1 diabetes.
Probiotics are living microorganisms that can have positive effects on the balance of intestinal microflora and the health of the host. Recent studies have shown that probiotics can promote the growth of beneficial microorganisms in the gut and improve the diabetes course. The effectiveness of probiotics has been reported in the treatment of some diseases such as insulin resistance, obesity, type 1 and 2 diabetes, and non-alcoholic fatty liver.
Proper control of blood glucose in children with type 1 diabetes has a direct effect on their quality of life and metabolism by reducing the risk of complications. Hosein Shabani-Mirzaee, Department of Pediatric Endocrinology, Tehran University of Medical Sciences, Tehran, Iran, and colleagues aimed to evaluate the effect of oral consumption of probiotics on glycosylated haemoglobin in children with type 1 diabetes.
For this purpose, the researchers conducted a single-blind randomized controlled clinical trial comprising 52 children with type 1 diabetes. They were categorized into two groups of 26 individuals each.
The probiotic group received a daily probiotic capsule for 90 days, along with a routine insulin therapy. The control group received only insulin therapy. Blood samples of both groups were taken to measure fasting plasma glucose, HbA1c, and lipid profiles at the trial's beginning and end.
Key findings of the study:
- HbA1c was high in both groups, but this increase was lower in the probiotic group (an increase of 0.1%) than in the control group (an increase of more than 0.4%). This decrease in HbA1c rising in the probiotic group was not statistically significant.
- The mean level of fasting plasma glucose in the probiotic group was significantly reduced compared to the control group.
- Acute complications of diabetes, like ketoacidosis or considerable hypoglycaemia, did not occur in the studied patients.
"The results suggest that the consumption of oral probiotics has no significant effect on HbA1c levels in children with T1DM," the researchers wrote. "Another result of this study was a significant reduction in the mean level of fasting plasma glucose in the probiotic group after the intervention."
"This issue may indicate the potential of future studies on the beneficial effect of probiotics with glycemic status in children with type 1 diabetes," they concluded.
Reference:
Shabani-Mirzaee H, Haghshenas Z, Malekiantaghi A, Vigeh M, Mahdavi F, Eftekhari K. The effect of oral probiotics on glycated haemoglobin levels in children with type 1 diabetes mellitus - a randomized clinical trial. Pediatr Endocrinol Diabetes Metab. 2023;29(3):128-133. doi: 10.5114/pedm.2023.132025. PMID: 38031828; PMCID: PMC10679923.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751